Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
T.MDP
Alternate Symbol(s):
MEDXF
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA...
. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Aug 04, 2021 1:43pm
RE:RE:RE:RE:I am still holding onto my shares.
My post makes sense. Your response is juvenile and silly. The company is followed by very few which is why the volume is so small. However, that does not mean there are no shareholders in the
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Aug 04, 2021 11:10am
Medexus Schedules Webinar
Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX:MDP.TO) (OTCQX:MEDXF) today announced that it has scheduled a webinar on Thursday, August 5, 2021 at 10:00 a.m
...more
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
posted May 08, 2024 9:00am by
Numinus Wellness Inc
-
|
"We are excited to enter this next stage of our development, which sharpens our focus on expanding access to psychedelic-assisted therapies and accelerates our path to profitability. We aim to empower a broader community of drug developers and healthcare providers by optimizing our therapy, research, and training expertise. This strategic focus is about bringing transformative treatments ...read more
(54)
•••
snootchybootchy
X
View Profile
View Bullboard History
Comment by
snootchybootchy
on Aug 04, 2021 11:03am
RE:RE:RE:I am still holding onto my shares.
Your posts again make zero sense. Just look back to what you said yesterday -- you said "this is a canadian company so very few, especially US investors, really follow the story" -- but
...more
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Aug 04, 2021 10:16am
RE:RE:I am still holding onto my shares.
I would be surprised if the stock price recovered much any tme soon. I think investors are dusturbed with this CRL. Based on Ken's statements over the last few months, he pretty much all but
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 04, 2021 9:50am
RE:I am still holding onto my shares.
I'm not selling either.
(3)
•••
simpleprofits
X
View Profile
View Bullboard History
Post by
simpleprofits
on Aug 04, 2021 4:51am
I am still holding onto my shares.
Hey guys, Well, I certainly wasn't expecting this. I don't think I will sell any shares as I got in at $6.10 I should have sold and took profits when I had the chance but I just didn't
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 03, 2021 2:47pm
RE:RE:RE:RE:RE:RE:MEDXF gets CRL
If you had 100% safe cure for cancer FDA would reject it because they look at how it would effect big pharma. Why the road block to list on Nasdaq? Who was pulling strings in the background to keep
...more
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Aug 03, 2021 11:25am
RE:RE:RE:RE:RE:MEDXF gets CRL
Disagree. This is a canadian company so very few, especially US investors, really follow the story. The volume is next to nothing. The valuation is normally discounted to what a US company would trade
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 03, 2021 11:09am
RE:RE:RE:RE:MEDXF gets CRL
Very true. If Treo was a sure thing the stock would have been much higher price. FDA games are a common thing and Yes the company needs to work with them quickly to get things back on track
...more
(54)
•••
snootchybootchy
X
View Profile
View Bullboard History
Comment by
snootchybootchy
on Aug 03, 2021 10:45am
RE:RE:RE:MEDXF gets CRL
Your posts do not make much sense. The uncertainty in Treo's approval from the FDA was already priced in. You think it would have been trading at around 1.5x TTM revs if investors thought Treo'
...more
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Aug 03, 2021 10:07am
RE:RE:MEDXF gets CRL
None of what you said is true. The ceo had mentioned many times he felt extremely confident approval would happen and that they would get expanded indication for pediatric. This was somewhat based on
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Aug 03, 2021 10:03am
Drug is approved in Canada and Europe
But the FDA decides to stick it to them for nothing. FDA believes it is smarter (give me a break they just allowed mRNA to be used as a vaccine without any approvals). than others. Here is what it is
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 03, 2021 9:45am
RE:MEDXF gets CRL
None of what you said is true. This is the FDA playing games. Revenues increasing and not listing on the Nasdaq was a good thing because of the games the US market plays. This is a temporary blow. A
...more
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Post by
Finallytherock
on Aug 03, 2021 8:12am
MEDXF gets CRL
Needs more trials. Company is falling apart. Ceo had indicated approval was in the bag. Decreasing revenues from products, shake up in management, no nasdaq listing. Awful,
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 30, 2021 10:06am
Getting pulled down
Shaking the tree for weak hands.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share